Thiazolidine derivatives, preparing same and pharmaceutical compositions comprising same
申请人:Takeda Chemical Industries, Ltd.
公开号:EP0008203A1
公开(公告)日:1980-02-20
Thiazolidine derivations of the general formula:
wherein R1 is alkyl, cycloalkyl, phenylalkyl, phenyl, a five-or six-membered heterocyclic group including one or two hetero-atoms selected from nitrogen, oxygen and sulphur or a group of the formula
(where R3 and R4 are the same or different and each is lower alkyl or R3 and R4 are combined with each other either directly or interrupted by a hetero-atom selected from nitrogen, oxygen and sulphur to form a five- or six-membered ring); R2 means a bond or a lower alkylene group; L1 and L2 are the same or different and each is lower alkyl or L' and L2 are combined to form an alkylene group, provided that, when R' is other than alkyl, L' and L2 may be further hydrogen,
are novel compounds and useful as, for example remedies for diabetes, hyperlipemia and so on of the mammals including human beings.
通式如下的噻唑烷衍生物
其中 R1 是烷基、环烷基、苯基烷基、苯基、包括一个或两个选自氮、氧和硫的杂原子的五或六元杂环基团或通式如下的基团
(其中 R3 和 R4 相同或不同,且各自为低级烷基,或 R3 和 R4 直接相互结合,或由选自氮、氧和硫的杂原子间断,形成五元或六元环);R2 指键或低级亚烷基;L1 和 L2 相同或不同,且各自为低级烷基,或 L' 和 L2 结合形成亚烷基,但当 R' 不是烷基时,L' 和 L2 可进一步为氢、
是新型化合物,可用于治疗包括人类在内的哺乳动物的糖尿病、高脂血症等。